Publications by authors named "Elizabeth A Erdman"

Objectives: The Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) Social Vulnerability Index (SVI) is used to guide policy making and resource allocation for emergency responses. However, limited research has explored the extent to which each variable contributes to the overall calculation of the SVI. We used a factor analysis approach to determine whether specific drivers of vulnerability exist at the state and national levels.

View Article and Find Full Text PDF

Background And Aims: Stimulant-involved overdose deaths are increasing throughout the United States. Because stimulant misuse (i.e.

View Article and Find Full Text PDF
Article Synopsis
  • The study presents a capture-recapture analysis of opioid use disorder (OUD) prevalence in Massachusetts from 2014 to 2020, aiming to estimate the size of this population at risk.
  • The findings indicate an overall increase in OUD prevalence, highlighting significant disparities, particularly among Hispanic and Black males and females.
  • This research is crucial for informing public health strategies and targeting resources for affected communities, especially as the global overdose crisis continues to escalate.
View Article and Find Full Text PDF

Infectious disease surveillance frequently lacks complete information on race and ethnicity, making it difficult to identify health inequities. Greater awareness of this issue has occurred due to the COVID-19 pandemic, during which inequities in cases, hospitalizations, and deaths were reported but with evidence of substantial missing demographic details. Although the problem of missing race and ethnicity data in COVID-19 cases has been well documented, neither its spatiotemporal variation nor its particular drivers have been characterized.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has highlighted the need for targeted local interventions given substantial heterogeneity within cities and counties. Publicly available case data are typically aggregated to the city or county level to protect patient privacy, but more granular data are necessary to identify and act upon community-level risk factors that can change over time.

Methods: Individual COVID-19 case and mortality data from Massachusetts were geocoded to residential addresses and aggregated into two time periods: "Phase 1" (March-June 2020) and "Phase 2" (September 2020 to February 2021).

View Article and Find Full Text PDF

To develop an imputation method to produce estimates for suppressed values within a shared government administrative data set to facilitate accurate data sharing and statistical and spatial analyses. We developed an imputation approach that incorporated known features of suppressed Massachusetts surveillance data from 2011 to 2017 to predict missing values more precisely. Our methods for 35 de-identified opioid prescription data sets combined modified previous or next substitution followed by mean imputation and a count adjustment to estimate suppressed values before sharing.

View Article and Find Full Text PDF